M. Torres

Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study

Á. Soriano, J. Mallolas, M. Laguno, 2022, Infectious Diseases and Therapy.

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

Á. Soriano, J. Mallolas, M. Laguno, 2022, Infection.

Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome

Á. Soriano, J. Miro, J. Mallolas, 2020, International Journal of Infectious Diseases.

Tocilizumab is associated with reduction of the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

Á. Soriano, M. Laguno, J. Nicolás, 2020, medRxiv.

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19

Á. Soriano, J. Mallolas, M. Laguno, 2022, Scientific Reports.

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study

Á. Soriano, M. Laguno, I. Alobid, 2021, BMJ Open.

Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19

X. Bosch, P. Moreno, A. López-Soto, 2021, Diagnostics.

Experience with the use of siltuximab in patients with SARS-CoV-2 infection

Á. Soriano, M. Laguno, M. Bodro, 2021, Revista Española de Quimioterapia.

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

Felipe García, Á. Soriano, M. Laguno, 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Experience with the use of siltuximab in patients with SARS-CoV-2 infection

Á. Soriano, M. Laguno, M. Bodro, 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.